Skip to content

Biomarkers of Traumatic Brain Injury With Tbit System

A Prospective, Multi-Center, Non-Randomized Study to Identify Intracranial Hemorrhage by Using an In-Vitro Device, Tbit™ System

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04107662
Enrollment
740
Registered
2019-09-27
Start date
2024-12-01
Completion date
2025-05-30
Last updated
2024-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Traumatic

Keywords

brain, injuries, disease, trauma, nervous system, wounds

Brief summary

A prospective, multi-center, non-randomized, pivotal study to assess the safety and efficacy of the Tbit™ System to aid in patient evaluation, suspected of traumatic brain injury, as adjunct companion test to radiologic standard of care, Cranial Computerized Tomography (CCT).

Interventions

DEVICETbit system

Suspected traumatic brain injury with head CT

Sponsors

BioDirection Inc
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years of age * Presents to the Emergency Department with suspected traumatic brain injury * Prescribed a non-contrast CCT as part of routine emergency care within 24 hours from injury * Blood sample collected for Tbit™ System within 12 hours of injury * Willing and able to provide informed consent or obtain consent from legal authorized representative (LAR)

Exclusion criteria

* Suspect of ischemic or hemorrhagic stroke with subsequent incidental trauma based on ED examination * Subject suspect of need of craniotomy for the acute trauma for this event * External signs compatible with a depressed skull fracture based on ED exam * Subject requiring administration of blood transfusion after injury and prior to study blood draw * Subject for whom timing of injury is unable to be estimated within 1 hour of certainty * Subject with a condition precluding entry into the CT scanner * Subject who had neurodegenerative disease or other neurological disorder including dementia, Parkinson's disease, multiple sclerosis, seizures, brain tumors, stroke or TIA within the last 30 days, or history of neurosurgery * Known or suspected to be pregnant * Prisoner or under incarceration * Participating in another clinical research study prior to this study completion

Design outcomes

Primary

MeasureTime frameDescription
Tbit™ System sensitivity and specificitywithin 12 hours from injury on day 0 of ED presentationTbit™ System sensitivity and specificity relative to the standard-of-care (SOC)
Cranial CT Intracranial Hemorrhage findings and the binary Tbit™ System (positive/negative)within 12 hours from injury on day 0 of ED presentationCranial CT Intracranial Hemorrhage findings (positive/negative) and the binary Tbit™ System results (positive/negative) of each sample.

Secondary

MeasureTime frameDescription
Safety and adverse event profile6 monthsSafety and adverse event profile
Overall accuracy of the Tbit™ Systemwithin 12 hours from injury on day 0 of ED presentationOverall accuracy of the Tbit™ System
Positive predictive value of the Tbit™ Systemwithin 12 hours from injury on day 0 of ED presentationPositive predictive value of the Tbit™ System
Negative predictive value of the Tbit™ Systemwithin 12 hours from injury on day 0 of ED presentationNegative predictive value of the Tbit™ System

Other

MeasureTime frameDescription
Tbit™ System User Satisfaction Survey6 monthsTbit™ System User Satisfaction Survey to evaluate the Tbit ease of use by device operators

Contacts

Primary ContactAdelina A Paunescu, PhD
apaunescu@medicept.com7815268152
Backup ContactTravis Jones, BSc
tjones@medicept.com6783207670

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026